Literature DB >> 19172510

Published international classification of retinoblastoma (ICRB) definitions contain inconsistencies--an analysis of impact.

Danielle E Novetsky1, David H Abramson, Jonathan W Kim, Ira J Dunkel.   

Abstract

PURPOSE: To determine the impact of subtle differences (most notably in their classification of group E eyes) in two published versions of the ICRB (Philadelphia and the Children's Hospital Los Angeles).
METHODS: Analysis of a series of 96 eyes with intra-ocular retinoblastoma.
RESULTS: The disparate criteria of the 2 published ICRB schemas affected group assignment of 5.2% of the eyes (25% of the group E eyes).
CONCLUSION: Discrepancies need to be reconciled to ensure accurate and uniform application of the ICRB.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19172510     DOI: 10.1080/13816810802452168

Source DB:  PubMed          Journal:  Ophthalmic Genet        ISSN: 1381-6810            Impact factor:   1.803


  20 in total

Review 1.  Retinoblastoma, the visible CNS tumor: A review.

Authors:  Helen Dimaras; Timothy W Corson
Journal:  J Neurosci Res       Date:  2018-01-03       Impact factor: 4.164

2.  Tumour size criteria for Group D and E eyes in the International Classification System for Retinoblastoma: effects on rates of globe salvage and high-risk histopathologic features.

Authors:  Jonathan W Kim; Sona N Shah; Sarah Green; John O'Fee; Benita Tamrazi; Jesse L Berry
Journal:  Acta Ophthalmol       Date:  2019-08-17       Impact factor: 3.761

3.  Indocyanine Green-Enhanced Thermotherapy for Retinoblastoma.

Authors:  Christiane E Al-Haddad; Marwan Abdulaal; Raya H Saab; Ziad F Bashshur
Journal:  Ocul Oncol Pathol       Date:  2014-10-31

Review 4.  The management of retinoblastoma.

Authors:  Ido D Fabian; Zerrin Onadim; Esin Karaa; Catriona Duncan; Tanzina Chowdhury; Irene Scheimberg; Shin-Ichi Ohnuma; M Ashwin Reddy; Mandeep S Sagoo
Journal:  Oncogene       Date:  2018-01-11       Impact factor: 9.867

Review 5.  Focal laser treatment in addition to chemotherapy for retinoblastoma.

Authors:  Ido D Fabian; Kenneth P Johnson; Andrew W Stacey; Mandeep S Sagoo; M A Reddy
Journal:  Cochrane Database Syst Rev       Date:  2017-06-07

Review 6.  Prognostication in eye cancer: the latest tumor, node, metastasis classification and beyond.

Authors:  T Kivelä; E Kujala
Journal:  Eye (Lond)       Date:  2012-12-21       Impact factor: 3.775

7.  Tumor Environment of Retinoblastoma, Intraocular Cancer.

Authors:  Dong Hyun Jo; Jin Hyoung Kim; Jeong Hun Kim
Journal:  Adv Exp Med Biol       Date:  2020       Impact factor: 2.622

Review 8.  Retinoblastoma.

Authors:  Helen Dimaras; Timothy W Corson; David Cobrinik; Abby White; Junyang Zhao; Francis L Munier; David H Abramson; Carol L Shields; Guillermo L Chantada; Festus Njuguna; Brenda L Gallie
Journal:  Nat Rev Dis Primers       Date:  2015-08-27       Impact factor: 52.329

9.  [Retinoblastoma].

Authors:  N Bornfeld; D Lohmann; N E Bechrakis; E Biewald
Journal:  Ophthalmologe       Date:  2020-04       Impact factor: 1.059

10.  Metastases and death rates after primary enucleation of unilateral retinoblastoma in the USA 2007-2017.

Authors:  Jonathan E Lu; Jasmine H Francis; Ira J Dunkel; Carol L Shields; Michael D Yu; Jesse L Berry; Kaitlin Kogachi; Alison H Skalet; Audra K Miller; Pranav R Santapuram; Anthony B Daniels; David H Abramson
Journal:  Br J Ophthalmol       Date:  2018-10-25       Impact factor: 4.638

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.